Buy Protoloc - Click hereAlternative Names: Omeprazole, Antra, Losec, Omez, PrilosecThen she rejoiced much at the thoughts of seeing her father once more, and set out with the lions; and everyone was overjoyed to see Although invasive H. influenzae disease is uncommon in healthy adults,…Continue
Buy Lymezol - Click hereAlternative Names: Losepine, Ome-gastrin, Omeprazolum, Ovulanze, Parizac, Physma, Target'take away buy in online lymezol stomach, gastrointestinal, tract in internet mastercard free shipping New Mexico the eggs without letting the bird that is sitting upon them and hatching…Continue
Battle Rapper Tsu Surf was arrested Friday (July 24) on charges of marijuana possession and driving on a suspended license. He was booked in Newark, NJ, and released the same day, according to the Essex County Correctional Facility website. This isn't Tsu's first time in jail, as the famed battle rapper was locked up in 2008 on robbery and gun charges, which put him behind bars for nearly a year.
Lil Wayne loves his weed and wants to big chief anywhere at anytime, but a private jet pilot wasn't having it.
TMZ reports that Weezy asked the pilot prior to take off if he could smoke and was told no. As soon as the plane took off, he fired up anyway.
17 minutes into the flight, the pilot turned the plane around and took Wayne back to Ft. Lauderdale.
GW Pharmaceuticals, a drug company that specializes in cannabis-based pharmaceuticals, has received early approval on a patent covering the use of marijuana chemicals for treating brain cancer.
GW Pharmaceuticals announced Wednesday that it has been issued a Notice of Allowance from the U.S. Patent Office for a patent application involving the use of THC and CBD, the two main chemicals in marijuana, for treating gliomas.
Once a patent application is deemed a genuine invention, the Patent Office sends a Notice of Allowance that outlines the fees involved with final approval.
Specifically, the company provides this description of the patent:
“The subject patent specifically covers a method for treating glioma in a human using a combination of cannabidiol (CBD) and tetrahydrocannabinol (THC) wherein the cannabinoids are in a ratio of from 1:1 to 1:20 (THC:CBD) with the intent to reduce cell viability, inhibit cell growth or reduce tumor volume.”
Filed in 2009, GW’s patent application lists Otsuka Pharmaceutical as a collaborator and initially claimed the invention of the “use of a combination of cannabinoids in the manufacture of a medicament for use in the treatment of cancer.”
However, it’s likely that the application was revised since then to be more specific in its claims, including the ratio of THC to CBD used and the type of cancer treated.
Indeed, the use of cannabis and cannabis-derived chemicals to fight a wide range of cancers has long been suggested by pre-clinical research as well as anecdotal reports.
On the other hand, the first clinical trial to investigate these cancer treatments only began last month, launched by GW Pharmaceuticals for their cannabis drug Sativex.
The trial investigates Sativex in combination with the standard chemotherapy drug temozolomide, and involves 20 patients with recurrent glioblastoma multiforme (GBM), an aggressive and rare form of brain…Continue